SmarTrend analyzes over 5,000 stocks simultaneously on an intraday basis using its pattern recognition technology to give you real-time alerts for stocks on the move -- so you can maximize your trading results. Let our system increase your market awareness.
Technical Analysis
- 8/28/2008 1:34:10 PM
By Chip Brian, SmarTrend Analytics Team
Today Emergent Biosolutions Inc. (NYSE:EBS) announced preliminary fiscal year 2007 and fiscal year 2008 outlook. Fiscal 2007 revenues are projected 20% above last year's revenues of $153 million at $183 million. Net income for the year is projected at $21 - $24 million. The company plans to report finalized earnings in February. Fiscal 2008 outlook is projected for net income of $20 million and revenue of $180 - $195 million.
Contact Chip Brian
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com. Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html
|
